Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 7/2009

01-07-2009 | Gastrointestinal Oncology

Prognostic Significance of Tumor Size in T3 Gastric Cancer

Authors: Xiaowen Liu, MD, Yu Xu, MD, Ziwen Long, MD, Huiyan Zhu, MD, Yanong Wang, MD, PhD

Published in: Annals of Surgical Oncology | Issue 7/2009

Login to get access

Abstract

Background

Clinical significance of tumor size remains elusive in gastric cancer. The aim of this study was to evaluate the prognostic value of tumor size in T3 gastric cancer.

Methods

A total of 273 patients with T3 gastric cancer who underwent curative D2 gastrectomy between 1996 and 2005 were evaluated. In terms of average value of tumor size, patients were divided into two groups according to tumor size: small-size group (SSG, tumor ≤6 cm) and large-size group (LSG, tumor >6 cm). The prognostic value of tumor size and the correlation between tumor size and other clinicopathologic factors were investigated.

Results

LSG accounted for 34.8% in all patients. Tumor size was correlated with histological type, lymphatic invasion, venous invasion, and resection type. The prognosis of LSG patients was worse than that of SSG patients. Multivariate analysis showed that type of resection, status of lymph nodes, metastatic lymph node ratio, and tumor size were defined as independent prognostic factors for patients with T3 gastric cancer. A comparison between LSG patients and SSG patients showed differences in the survival of those with stage IIIB and IV disease.

Conclusions

Tumor size is a simple and reliable prognostic factor for patients with T3 gastric cancer; it might be a candidate for the gastric cancer staging system.
Literature
1.
Adachi Y, Mori M, Maehara Y, et al. Dukes’s classification: a valid prognostic indicator for gastric cancer. Gut. 1994;35:1368–71.PubMedCrossRef
2.
Maruyama K. The most important prognostic factors for gastric cancer patients: a study using univariate and multivariate analyses. Scand J Gastroenterol. 1987;22:63–8.CrossRef
3.
Galizia G, Lieto E, Orditura M, et al. Epidermal growth factor receptor (EGFR) expression is associated with a worse prognosis in gastric cancer patients undergoing curative surgery. World J Surg. 2007;31:1458–68.PubMedCrossRef
4.
Kim J, Sohn S, Chae Y, et al. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with gastric cancer. Ann Oncol. 2007;18:1030–6.PubMedCrossRef
5.
Griffiths EA, Pritchard SA, Valentine HR, et al. Hypoxiainducible factor-1 alpha expression in gastric carcinogenesis sequence and its prognostic role in gastric and gastrooesophageal adenocarcinomas. Br J Cancer. 2007;96:95–103.PubMedCrossRef
6.
Aung PP, Oue N, Mitani Y, et al. Systematic search for gastric cancer-specific genes based on SAGE data: melanoma inhibitory activity and matrix metalloproteinase-10 are novel prognostic factors in patients with gastric cancer. Oncogene. 2006;25:2546–57.PubMedCrossRef
7.
Adachi Y, Oshiro T, Mori M, et al. Tumor size as a simple prognostic indicator for gastric carcinoma. Ann Surg Oncol. 1997;4:137–40.PubMedCrossRef
8.
Saito H, Osaki T, Murakami D, et al. Macroscopic tumor size as a simple prognos- tic indicator in patients with gastric cancer. Am J Surg. 2006;192:296–300.PubMedCrossRef
9.
Wang X, Wan F, Pan J, et al. Tumor size: a non-neglectable independent prognostic factor for gastric cancer. J Surg Oncol. 2008;97:236–40.PubMedCrossRef
10.
Yoo CH, Noh SH, Kim YI, et al. Comparison of prognostic significance of nodal staging between old (4th edition) and new (5th edition) UICC TNM classification for gastric carcinoma. World J Surg. 1999;23:492–8.PubMedCrossRef
11.
12.
Sobin LH, Wittekind CH, editors. TNM: classification of malignant tumours. 6th ed. New York: Wiley-Liss; 2002.
13.
Sierra A, Regueira FM, Hernandez-Lizoain JL, et al. Role of the extended lymphadenectomy in gastric cancer surgery: experience in a single institution. Ann Surg Oncol. 2003;10:219–26.PubMedCrossRef
14.
Bando E, Yonemura Y, Taniguchi K, et al. Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol. 2002;9:775–84.PubMedCrossRef
15.
Marchet A, Mocellin S, Ambrosi A, et al. The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients. Ann Surg. 2007;245:543–52.PubMedCrossRef
16.
Japanese Gastric Cancer Association. Japanese classification of gastric cancer, 2nd English ed. Gastric Cancer. 1998;1:8–24.CrossRef
17.
Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–81.CrossRef
18.
Cox DR. Regression models and life-tables. J R Stat Soc B. 1972;34:187–220.
19.
Hyung WJ, Noh SH, Yoo CH, et al. Prognostic significance of metastatic lymph node ratio in T3 gastric cancer. World J Surg. 2002;26:323–9.PubMedCrossRef
20.
Kattan MW, Karpeh MS, Mazumdar M, et al. Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol. 2003;21:3647–50.PubMedCrossRef
21.
Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11–20.PubMedCrossRef
22.
Tanemura H, Oshita H, Kanno A, et al. Neoadjuvant chemotherapy using TS-1 and CDDP against large type 3/Type 4/Bulky N 2 advanced gastric cancer. Gan To Kagaku Ryoho. 2005;32:2079–85.PubMed
Metadata
Title
Prognostic Significance of Tumor Size in T3 Gastric Cancer
Authors
Xiaowen Liu, MD
Yu Xu, MD
Ziwen Long, MD
Huiyan Zhu, MD
Yanong Wang, MD, PhD
Publication date
01-07-2009
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 7/2009
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-009-0449-x

Other articles of this Issue 7/2009

Annals of Surgical Oncology 7/2009 Go to the issue

Breast Oncology

Video-Assisted Skin-Sparing Breast-Conserving Surgery for Breast Cancer and Immediate Reconstruction with Autologous Tissue: Clinical Outcomes

Translational Research and Biomarkers

Preoperative u-PAR Gene Expression in Bone Marrow Indicates the Potential Power of Recurrence in Breast Cancer Cases

Consensus Report: Resectable and Borderline Resectable Pancreas Cancer

Surgical Treatment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement by Evans et al.

Multimedia Article

Systematic Subsegmentectomy by Ultrasound-Guided Finger Compression for Hepatocellular Carcinoma in Cirrhosis

Gastrointestinal Oncology

In Reply: Abdominal-Transhiatal Resection for Adenocarcinoma of the Esophagogastric Junction

Gynecologic Oncology

Pathological Diagnosis and Cytoreduction of Cardiophrenic Lymph Node and Pleural Metastasis in Ovarian Cancer Patients Using Video-Assisted Thoracic Surgery